PAVMED INC - COM (PAVM)

Historical Holders from Q3 2016 to Q4 2023

Type / Class
Equity / COM
Symbol
PAVM on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PAVMED INC - COM (PAVM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2023 Q4 0 $0 -$3,006,573 0
2023 Q3 12,457,322 $3,667,725 +$924,640 29.46% 63
2023 Q2 9,271,344 $3,780,539 -$349,205 40.78% 56
2023 Q1 9,913,789 $3,702,374 +$117,852 37.35% 55
2022 Q4 9,672,101 $4,638,902 -$2,582,243 48% 58
2022 Q3 12,447,373 $10,702,088 +$429,136 86.01% 62
2022 Q2 11,999,897 $11,228,071 -$8,344,099 93.5% 68
2022 Q1 20,405,801 $27,020,616 -$10,361,562 132.01% 91
2021 Q4 26,453,496 $65,366,935 -$16,336,430 246.02% 102
2021 Q3 23,253,190 $198,234,329 +$21,389,623 854% 104
2021 Q2 21,047,663 $134,735,894 +$21,054,151 640% 98
2021 Q1 18,052,615 $80,163,600 +$41,135,494 444.12% 88
2020 Q4 8,871,107 $18,806,518 +$4,172,018 211.88% 63
2020 Q3 6,852,265 $12,207,357 +$459,914 177.98% 56
2020 Q2 6,534,150 $13,789,836 +$7,032,000 211.01% 51
2020 Q1 3,188,480 $6,322,000 +$1,642,925 198.02% 22
2019 Q4 2,319,688 $2,782,000 +$99,301 119.97% 12
2019 Q3 2,246,190 $2,153,000 +$90,317 95.86% 13
2019 Q2 2,145,488 $2,444,000 +$1,810,383 113.58% 12
2019 Q1 556,137 $610,000 +$27,283 109.27% 7
2018 Q4 534,792 $512,000 -$131,451 94.91% 7
2018 Q3 638,267 $828,000 -$913,156 129.54% 13
2018 Q2 1,779,206 $1,689,000 +$586,496 94.54% 9
2018 Q1 1,136,809 $1,863,000 +$1,746,633 163.95% 11
2017 Q4 61,518 $141,000 -$223,648 229.13% 6
2017 Q3 107,241 $582,000 +$54,330 542.19% 7
2017 Q2 106,726 $481,000 +$260,629 450.26% 5
2017 Q1 48,507 $243,000 +$16,399 500.77% 6
2016 Q4 45,264 $312,000 -$656 688.25% 3
2016 Q3 23,031 $321,000 +$321,000 1,181.1% 3